Gabapentin-Induced Rhabdomyolysis in a Patient with Diabetic Neuropathy

被引：10

作者：

Bilgir, Oktay ^{[1
]}

Calan, Mehmet ^{[1
]}

Bilgir, Ferda ^{[2
]}

Kebapcilar, Levent ^{[1
]}

Yuksel, Arif ^{[1
]}

Yildiz, Yasar ^{[1
]}

Sari, Ismail ^{[1
]}

机构：

[1] Izmir Bozyaka Educ & Res Hosp, Dept Internal Med 2, Izmir, Turkey

[2] Buca State Hosp, Dept Internal Med, Izmir, Turkey

来源：

INTERNAL MEDICINE | 2009年 / 48卷 / 12期

关键词：

Gabapentin; rhabdomyolysis; diabetic neuropathy; RENAL-FAILURE; MYOPATHY; PAIN;

D O I：

10.2169/internalmedicine.48.1766

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gabapentin (GBP) is a drug which is frequently used in diabetic neuropathy. Common adverse effects of GBP include drowsiness, dizziness, ataxia, somnolence, and fatigue. Rhabdomyolysis is an extremely rare side effect of GBP. In this report we describe a case of GBP-induced rhabdomyolysis in a 63-year-old diabetic woman. She presented with severe muscle pain in her extremities, fatigue, decreased urine output and urine discoloration within 3 weeks after starting treatment with GBP (900 mg/day) for diabetic neuropathy. Laboratory tests revealed extreme elevations of muscle enzymes, increased creatinine and potassium levels. She required hemodialysis as a result of anuria. Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of GBP resulted in resolution of clinical and biochemical features of rhabdomyolysis.

引用

页码：1085 / 1087

页数：3

共 17 条

[1] Alden KJ, 2001, J PHARMACOL EXP THER, V297, P727
[2] Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark, DWJ
Strandell, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 473 - 479
[3] Dogukan Ayhan, 2006, Hemodial Int, V10, P168, DOI 10.1111/j.1542-4758.2006.00089.x
[4] Gomez-Perez FJ., 2004, The British Journal of Diabetes Vascular Disease, V4, P173
[5] Pathophysiology and clinical presentations of rhabdomyolysis
Guis, S
Mattei, JP
Cozzone, PJ
Bendahan, D
[J]. JOINT BONE SPINE, 2005, 72 (05) : 382 - 391
[6] Gabapentin-induced myopathy in 2 patients on short daily hemodialysis
Lipson, J
Lavoie, S
Zimmerman, D
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) : E100 - E104
[7] Inhibition of the rat brain sodium channel Nav1.2 after prolonged exposure to gabapentin
Liu, Yi
Qin, Ning
Reitz, Tasha
Wang, Yan
Flores, Christopher M.
[J]. EPILEPSY RESEARCH, 2006, 70 (2-3) : 263 - 268
[8] Rhabdomyolysis associated with haloperidol without evidence of NMS
Marinella, MA
[J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (7-8) : 927 - 928
[9] Gabapentin for neuropathic pain: Systematic review of controlled and uncontrolled literature
Mellegers, MA
Furlan, AD
Mailis, A
[J]. CLINICAL JOURNAL OF PAIN, 2001, 17 (04) : 284 - 295
[10] Gabapentin Toxicity in Renal Failure: The Importance of Dose Adjustment
Miller, Alice
Price, Grant
[J]. PAIN MEDICINE, 2009, 10 (01) : 190 - 192

← 1 2 →